Decriminalization of non-medical cannabis in the United States drug, which contains a very active component delta-9-tetrahydrocannabinol (THC). For thousands of years, it was used for medical purposes in many different parts of the world. Recent studies also agreed that THC had great potential benefits for medical purposes. A number of patients who have HIV, multiple sclerosis (MS), neuropathic chronic pain, and cancer were under medical marijuana treatment. The treatments could either be smoke on cannabis or oral preparations, which were synthetic THC and synthetic equivalent. According to Medical Uses of Marijuana (Cannabis sativa), patients with HIV reported that the drug reduced mixed neuropathic pain more significantly in comparison
History of the Food and Drug Administration 510(k) k033391 in January 2004, the FDA granted Dr. Ronald Sherman permission to produce and market medical maggots for use in humans or other animals as a prescription medical device. Medical maggots represent the first living organism allowed by the Food and Drug Administration for production and marketing as a prescription medical device. In June 2004, the FDA cleared "Hirudo medicinalis" (medicinal leeches) as the second living organism to be used as a medical devices. Most federal laws concerning the FDA are part of the Food, Drug and Cosmetic Act, (first passed in 1938 and extensively amended since) and are